# Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors   for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV

Federal contract opportunity, via Kontrakk.

- **Agency:** HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH NIDA
- **Notice ID:** 39c13aa6756e4ac2bc3ab83cc43acf71
- **Solicitation number:** 75N95026R0007
- **Notice type:** Combined Synopsis/Solicitation
- **Set-aside:** No Set aside used
- **NAICS:** 541690
- **Place of performance:** Bethesda, MD
- **Posted:** July 27, 2026
- **Response deadline:** July 30, 2026
- **View on Kontrakk:** https://kontrakk.com/contracts/39c13aa6756e4ac2bc3ab83cc43acf71
- **View on SAM.gov:** https://sam.gov/workspace/contract/opp/39c13aa6756e4ac2bc3ab83cc43acf71/view

## Description

Full description available on SAM.gov: https://sam.gov/workspace/contract/opp/39c13aa6756e4ac2bc3ab83cc43acf71/view

## Points of contact

- KNIGHTLY, ROBIN D · robin.knightly@nih.gov · 13018275302 (primary)